Skip to main content Skip to navigation

Dr Angela Noufaily

Job Title
Senior Research Fellow
WMS - Health Sciences
Research Interests

My main interest lies in applying my statistical background (regression models, survival analysis, time series analysis, distribution theory, experimental design) to the benefit of the medical field. I collaborate on two major randomized clinical trials studies: the Physiotherapy Rehabilitation for Osteoporotic Vertebral Fracture (PROVE) trial led by the University of Oxford and the Canadian Institute of Health Research project EPOCH which involves data from and collaborations with 7 countries including UK, Canada, Australia, Netherlands, Sweden. I also collaborate with Public Health England on projects involving outbreak detection of syndromes and surveillance for genome sequenced organisms. Through the Research Design Service West Midlands, I currently contribute to collaborative funding applications by joining multidisciplinary research teams and providing statistical consulting to local health care researchers in Coventry, Warwickshire and the University of Warwick.


I am a Senior Research Fellow in Medical Statistics at Warwick Medical School. I am part of the Statistics and Epidemiology group with main interests in randomized controlled trials and epidemiological science. I also consult on bids for funding via the Research Design Service (RDS). Prior to that, I was a Research Associate at the Open University Mathematics and Statistics Department where I worked on a three-year Medical Research Council project entitled "Statistical outbreak detection methods for large multiple surveillance systems" with Prof Paddy Farrington as Principal Investigator. I have a PhD in Statistics entitled "Parametric quantile regression based on the generalised gamma distribution", a MSc in Pure Mathematics and a BSc in Statistics.

Title Funder Award start Award end
Research Design Service renewal 2018 National Institute for Health Research (DoH) 01 Oct 2018 30 Sep 2023
Evaluating the ReSPECT process in the community setting. National Institute for Health Research (NIHR DoH) 01 May 2021 30 Apr 2023
Prospective, Randomized, Parallel-Group, Open-Label Study to Evaluate the Efficacy and Safety of IMU-838, in Combination with Oseltemivir, in Adults with Coronavirus Disease 19 ? IONIC study. LifeArc 18 Jun 2020 17 Jun 2021